Industry keeps up the pressure on UK early access scheme; new 'promising innovation medicine' designation in sight
This article was originally published in Scrip
Executive Summary
The life sciences industry in the UK is continuing to put pressure on the government in an effort to make it deliver on the much-vaunted but still-to-materialize early access to medicines scheme. There is speculation that an announcement on the scheme is not far off, with a new “promising innovation medicine” designation expected to be introduced as part of it.